The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 21700453 |
56 |
Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist. |
Msd |
| 21458261 |
55 |
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists. |
Msd |
| 7752199 |
71 |
Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists. |
Medical College of Ohio |
| 19800231 |
92 |
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists. |
Schering-Plough Research Institute |
| 17300166 |
88 |
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8. |
University of Montpellier |
| 16297621 |
17 |
Pyridobenzodiazepines: a novel class of orally active, vasopressin V2 receptor selective agonists. |
Wyeth Research |
| 15857144 |
10 |
Design of benzophenone-containing photoactivatable linear vasopressin antagonists: pharmacological and photoreactive properties. |
University of Montpellier |
| 1331448 |
101 |
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product. |
Merck Research Laboratories |
| 1732523 |
46 |
Preparation and biological activities of potential vasopressin photoaffinity labels. |
University of Sherbrooke |
| 15149662 |
71 |
Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists. |
Johnson and Johnson Pharmaceutical Research and Development |
| 11755361 |
24 |
N-Methylbenzanilide derivatives as a novel class of selective V(1A) receptor antagonists. |
Yamanouchi Pharmaceutical |
| 21688787 |
295 |
New, potent, selective, and short-acting peptidic V1a receptor agonists. |
Ferring Research Institute |
| 20550119 |
96 |
Oral oxytocin antagonists. |
Drugmoldesign |
| 7807119 |
5 |
Khusimol, a Non-Peptide Ligand for Vasopressin V1a Receptors |
TBA |
| | 66 |
Non-peptide oxytocin antagonists: identification and synthesis of a potent camphor aminosuccinimide |
TBA |
| 17942308 |
62 |
Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies. |
Johnson & Johnson Pharmaceutical Research & Development |
| 12798333 |
56 |
Structure-activity study of novel tricyclic benzazepine arginine vasopressin antagonists. |
Wyeth Research |
| 12036368 |
59 |
Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor. |
Yamanouchi Pharmaceutical |
| 11087564 |
30 |
Novel design of nonpeptide AVP V(2) receptor agonists: structural requirements for an agonist having 1-(4-aminobenzoyl)-2,3,4, 5-tetrahydro-1H-1-benzazepine as a template. |
Otsuka Pharmaceutical |
| 10782666 |
46 |
The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2,4,5,6-tetrahydropyrazolo[3,4-d]thieno[3,2-b]azepines. |
Wyeth-Ayerst Research |
| 10406633 |
32 |
5-fluoro-2-methyl-N-[5-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists. |
Wyeth-Ayerst Research |
| 10406632 |
11 |
4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists. |
Wyeth-Ayerst Research |
| 10340620 |
30 |
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency. |
Merck Research Laboratories |
| 9651149 |
54 |
5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors. |
Wyeth-Ayerst Research |
| 8784453 |
134 |
Orally active, nonpeptide vasopressin V2 receptor antagonists: a novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds. |
Otsuka Pharmaceutical |
| 8393113 |
114 |
Orally active, nonpeptide vasopressin V1 antagonists. A novel series of 1-(1-substituted 4-piperidyl)-3,4-dihdyro-2(1H)-quinolinone. |
Otsuka Pharmaceutical |
| 8126695 |
35 |
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor. |
Merck Research Laboratories |
| 8021923 |
27 |
A new series of photoactivatable and iodinatable linear vasopressin antagonists. |
Upr 9023 Cnrs |
| 7473590 |
37 |
1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist. |
Merck Research Laboratories |
| 30199637 |
172 |
LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. |
Umr7200 Cnrs/Universit£ |
Search and Browse
